BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15658450)

  • 21. [New molecular markers within the chronic myeloproliferative disorders. I: the PRV-1 gene].
    Larsen TS; Pallisgaard N; Christensen JH; Gram-Hansen P; Kerndrup GB; Møller MB; Hasselbalch HC
    Ugeskr Laeger; 2006 Sep; 168(39):3295-9. PubMed ID: 17032591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transition of polycythemia vera to chronic neutrophilic leukemia.
    Higuchi T; Oba R; Endo M; Harada H; Mori H; Niikura H; Omine M; Fujita K
    Leuk Lymphoma; 1999 Mar; 33(1-2):203-6. PubMed ID: 10194140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic neutrophilic leukemia--report of a case and review of the literature.
    Wang JS; Ho CH; Lin CK
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Aug; 46(2):109-12. PubMed ID: 2177362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Differential diagnosis of chronic myeloid leukemia and the related disorders].
    Ashida T; Kanamaru A
    Nihon Rinsho; 2001 Dec; 59(12):2358-62. PubMed ID: 11766339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis and therapy of chronic myeloproliferative disorders].
    Kimura A
    Nihon Naika Gakkai Zasshi; 1998 Mar; 87(3):507-12. PubMed ID: 9577584
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
    Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Periodic acid-Schiff reaction of erythroblasts in erythremic myelosis and neutrophil alkaline phosphatase activity in paroxysmal nocturnal hemoglobinuria].
    Horie K
    Rinsho Byori; 1969 Jan; 17(1):42-3. PubMed ID: 4181627
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
    Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myeloproliferative syndromes: diagnosis and therapeutic options.
    Hellmann A
    Pol Arch Med Wewn; 2008 Dec; 118(12):756-60. PubMed ID: 19202955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chronic myeloid leukemia with progression to polycythemia vera].
    Campo MC; Fortún A; Travieso J
    Sangre (Barc); 1992 Jun; 37(3):207-8. PubMed ID: 1440100
    [No Abstract]   [Full Text] [Related]  

  • 31. Cytochemical alkaline phosphatase test of mature neutrophils in the different diagnosis of myeloproliferative disorders.
    BLUM LL
    J Indiana State Med Assoc; 1962 Dec; 55():1783-4. PubMed ID: 13971867
    [No Abstract]   [Full Text] [Related]  

  • 32. Induction of neutrophil alkaline phosphatase gene expression by granulocyte colony-stimulating factor in chronic myelogenous leukemia.
    Tsushita K; Hotta T; Ichikawa A; Murate T; Saito H
    Int J Hematol; 1993 Jan; 57(1):45-52. PubMed ID: 7682859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.
    Thiele J; Kvasnicka HM
    Pathobiology; 2007; 74(2):89-96. PubMed ID: 17587880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukocyte alkaline phosphatase (LAP) by flow cytometry.
    Eshel E; Sharabi-Nov A; Dally N
    MLO Med Lab Obs; 2013 Aug; 45(8):22, 24, 26. PubMed ID: 24205536
    [No Abstract]   [Full Text] [Related]  

  • 35. [Erythrocyte glutathione reductase (EGR)].
    Yasuda K; Hiraoka M
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():809-11. PubMed ID: 15658456
    [No Abstract]   [Full Text] [Related]  

  • 36. [The significance of muramidase (lysozyme) determinations in hematologic diseases].
    Mets T; Carlier A; Van Hove W
    Ned Tijdschr Geneeskd; 1976 Nov; 120(47):2039-44. PubMed ID: 1070575
    [No Abstract]   [Full Text] [Related]  

  • 37. [Alkaline phosphatase activity of the granulocytes in polycythemia vera and myelofibrosis].
    Mariańska B; Leszko B; Maj S; Apel D
    Acta Haematol Pol; 1987; 18(1-2):23-7. PubMed ID: 3434154
    [No Abstract]   [Full Text] [Related]  

  • 38. [Erythrocyte transketolase].
    Yasuda K; Hiraoka M
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():823-6. PubMed ID: 15658460
    [No Abstract]   [Full Text] [Related]  

  • 39. Diagnosis and management of neutrophilic myeloid neoplasms.
    Schwede M; Gotlib J; Shomali W
    Clin Adv Hematol Oncol; 2021 Jul; 19(7):450-459. PubMed ID: 34236344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sorbitol dehydrogenase (SDH)].
    Okamoto Y; Tanaka S
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():827-9. PubMed ID: 15658461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.